We are live on ! Find out more

Large Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
BDX icon
26
Becton Dickinson
BDX
$49.8B
$49.8B $182.75 1.44%
EW icon
27
Edwards Lifesciences
EW
$48.6B
$48.6B $84.24 1.8%
A icon
28
Agilent Technologies
A
$47.4B
$47.4B $168.17 0.54%
HUM icon
29
Humana
HUM
$46.5B
$46.5B $387.12 2.37%
VEEV icon
30
Veeva Systems
VEEV
$46.1B
$46.1B $284.84 0.83%
TEVA icon
31
Teva Pharmaceutical Industries Limited
TEVA
$45.8B
$45.8B $39.25 0.18%
XLV icon
32
State Street Health Care Select Sector SPDR ETF
XLV
$43.3B
$43.3B $168.16 0.39%
IQV icon
33
IQVIA
IQV
$42.6B
$42.6B $258.88 0.3%
WAT icon
34
Waters Corp
WAT
$42.2B
$42.2B $429.13 1.57%
HLN icon
35
Haleon
HLN
$40.7B
$40.7B $9.26 2.66%
IDXX icon
36
Idexx Laboratories
IDXX
$40.4B
$40.4B $513.14 1.28%
RVMD icon
37
Revolution Medicines
RVMD
$40.3B
$40.3B $188.12 6.35%
ILMN icon
38
Illumina
ILMN
$40B
$40B $264.57 1.19%
ONC
39
BeOne Medicines Ltd
ONC
$39.6B
$39.6B $350.13 3.82%
BIIB icon
40
Biogen
BIIB
$32.3B
$32.3B $218.43 1.67%
RMD icon
41
ResMed
RMD
$31.9B
$31.9B $226.73 0.33%
CNC icon
42
Centene
CNC
$31.9B
$31.9B $64.54 0.69%
DXCM icon
43
DexCom
DXCM
$31.9B
$31.9B $84.41 0.13%
MDLN
44
Medline Inc
MDLN
$31.4B
$31.4B $35.74 0.82%
MTD icon
45
Mettler-Toledo International
MTD
$30.6B
$30.6B $1,529.46 0.26%
ALC icon
46
Alcon
ALC
$30.5B
$30.5B $63.13 0.21%
ZTS icon
47
Zoetis
ZTS
$30.2B
$30.2B $73.08 2.14%
ALNY icon
48
Alnylam Pharmaceuticals
ALNY
$30B
$30B $224.53 0.05%
GEHC icon
49
GE HealthCare
GEHC
$29B
$29B $64.22 0.7%
WST icon
50
West Pharmaceutical
WST
$25.6B
$25.6B $363.27 0.88%

Large Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 103 large cap Healthcare stocks — companies in the Healthcare sector with a market cap between $10B and $200B — worth a combined $4.37T.

The largest by market cap are Gilead Sciences (GILD) at $182B, Abbott (ABT) at $170B and Novo Nordisk (NVO) at $169B.

Among institutional investors, CVS Health (CVS) drew the most net new fund positions in Q2 2026: 323 funds opened new positions, taking total fund holders up 194 (10%) quarter-over-quarter.

  • Combined market cap: $4.37T across 103 stocks.
  • Large Cap: market cap between $10B and $200B.
  • Largest constituent: Gilead Sciences (GILD), $182B market cap.
  • Most net new fund positions in Q2 2026: CVS Health (CVS), +194 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.